Hypotension After Anesthetic Induction With Remimazolam in Elderly
Status:
Not yet recruiting
Trial end date:
2023-12-31
Target enrollment:
Participant gender:
Summary
Even though remimazolam is known to be safely administered without hemodynamic instability,
hypotension is the one of the common side effects of remimazolam. Because elderly patients
are susceptible to hypotension due to old age, multimodality, and multiple medications,
hypotension can be harmful in elderly patients. Remimazolam can be administered either bolus
or continuous for anesthetic induction. In our study the investigators aimed to compare the
incidence of hypotension after anesthetic induction using remimazolam by bolus injection and
continuous infusion in elderly patients.